Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Michael Schüpbach »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Michael Schupbach < Michael Schüpbach < Michael Sharman  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000211 (2010) Fanny Pineau [France] ; Michael Schüpbach [France] ; Jean-Christophe Corvol [France] ; Constance Flamand-Rouvière [France] ; Marie Vidailhet [France] ; Emmanuel Roze [France]Long‐standing paraphilia induced by dopamine agonists in Parkinson's disease
000302 (2008) Mouna Ben Djebara [France] ; Yulia Worbe [France] ; Michael Schüpbach [France] ; Andreas Hartmann [France]Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome
000304 (2008) Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Lévy [France] ; Eric Bardinet [France] ; Jérôme Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France]Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom
000315 (2007) Michael Schüpbach [France] ; Ebba Lohmann [France] ; Mathieu Anheim [France] ; Suzanne Lesage [France] ; Virginie Czernecki [France] ; Sadek Yaici [France] ; Yulia Worbe [France] ; Perrine Charles [France] ; Marie-Laure Welter [France] ; Pierre Pollak [France] ; Alexandra Dürr [France] ; Yves Agid [France] ; Alexis Brice [France]Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Humans
4Male
3Middle Aged
3Nervous system diseases
2Adult
2Aged
2Female
2Parkinson Disease (drug therapy)
2Parkinson disease
1Antipsychotic Agents (therapeutic use)
1Apathy
1Aripiprazole
1Coprolalia
1Deep Brain Stimulation (adverse effects)
1Deep Brain Stimulation (methods)
1Deep brain stimulation
1Dopamine
1Dopamine Agonists (adverse effects)
1Dopamine Agonists (therapeutic use)
1Gilles de la Tourette syndrome
1Glycine (genetics)
1Human
1Indoles (pharmacology)
1Indoles (therapeutic use)
1LRRK2
1Mood Disorders (etiology)
1Mutation
1Paraphilias (chemically induced)
1Parkinson Disease (physiopathology)
1Parkinson Disease (psychology)
1Parkinson's disease
1Parkinsonian Disorders (genetics)
1Parkinsonian Disorders (pathology)
1Parkinsonian Disorders (therapy)
1Parkinsonism
1Piperazines (therapeutic use)
1Protein-Serine-Threonine Kinases (genetics)
1Quinolones (therapeutic use)
1Receptors, Dopamine D2 (drug effects)
1Receptors, Dopamine D3 (drug effects)
1Retrospective Studies
1Serine (genetics)
1Subthalamic Nucleus (physiology)
1Subthalamic Nucleus (physiopathology)
1Subthalamic Nucleus (surgery)
1Subthalamic nucleus
1Threonine (genetics)
1Time Factors
1Tourette Syndrome (drug therapy)
1Treatment Outcome
1apathy
1aripiprazole
1coprolalia
1dardarine
1deep brain stimulation
1dopaminergic agonist
1genetics
1subthalamic nucleus
1subthalamic stimulation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Michael Schüpbach" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Michael Schüpbach" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Michael Schüpbach
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024